{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T15:37:46Z","timestamp":1726760266938},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008725","name":"ANII","doi-asserted-by":"crossref","award":["FMV 6335"],"award-info":[{"award-number":["FMV 6335"]}],"id":[{"id":"10.13039\/100008725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"PEDECIBA","award":["URU\/06\/004"],"award-info":[{"award-number":["URU\/06\/004"]}]},{"name":"PRONII"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasitology International"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.parint.2015.03.005","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T13:50:26Z","timestamp":1428328226000},"page":"295-298","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Finding of leishmanicidal activity of 14-hydroxylunularin in mice experimentally infected with Leishmania infantum"],"prefix":"10.1016","volume":"64","author":[{"given":"Ma. Elva","family":"Serna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisel","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Schinini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Peixoto de Abreu Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Pandolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonieta","family":"Rojas de Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parint.2015.03.005_bb0005","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.parint.2015.03.005_bb0010","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nrmicro981","article-title":"Leishmaniasis","volume":"2","author":"Desjeux","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.parint.2015.03.005_bb0015","first-page":"195","article-title":"Visceral leishmaniasis as a threat for non-endemic countries","volume":"55","author":"Gorski","year":"2009","journal-title":"Wiad Parazytol"},{"issue":"5","key":"10.1016\/j.parint.2015.03.005_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.parint.2015.03.005_bb0025","article-title":"Research priorities for chagas disease, human african trypanosomiasis and leishmaniasis","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.parint.2015.03.005_bb0030","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0169-4758(00)01637-9","article-title":"The strange case of Leishmania chagasi","volume":"16","author":"Mauricio","year":"2000","journal-title":"Parasitol Today"},{"key":"10.1016\/j.parint.2015.03.005_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(04)57001-X","article-title":"Canine leishmaniasis","volume":"57","author":"Alvar","year":"2004","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.parint.2015.03.005_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1746-6148-4-45","article-title":"Transmission potential, skin inflammatory response, and parasitism of symptomatic and asymptomatic dogs with visceral leishmaniasis","volume":"4","author":"Ver\u00e7osa","year":"2008","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.parint.2015.03.005_bb0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.vetpar.2010.01.044","article-title":"Relationship between dog culling and incidence of human visceral leishmaniasis in an endemic area","volume":"170","author":"Nunes","year":"2010","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.parint.2015.03.005_bb0050","series-title":"Proceedings of the V Paraguayan Congress of Pediatrics, 1996, Asunci\u00f3n, Paraguay","article-title":"Leishmaniasis visceral en el Paraguay. Reporte de un caso con diagn\u00f3stico histol\u00f3gico y parasitol\u00f3gico","author":"Kasamatsu","year":"1996"},{"key":"10.1016\/j.parint.2015.03.005_bb0055","first-page":"18","article-title":"Focos de Leismaniasis Visceral canina de Lambar\u00e9 y Villa Elisa","volume":"18","author":"Canese","year":"1998","journal-title":"Rev Parag Microbiol"},{"key":"10.1016\/j.parint.2015.03.005_bb0060","first-page":"1","article-title":"Leishmaniasis visceral: \u00bfRe-emergente o Re-descubierta en Paraguay?","volume":"23","author":"Canese","year":"2003","journal-title":"Rev Parag Microbiol"},{"issue":"3","key":"10.1016\/j.parint.2015.03.005_bb0065","first-page":"167","article-title":"Gran incremento de Leishmaniasis visceral humana en Paraguay","volume":"37","author":"Canese","year":"2010","journal-title":"Pediatria"},{"key":"10.1016\/j.parint.2015.03.005_bb0070","first-page":"175","article-title":"Caracter\u00edsticas epidemiol\u00f3gicas y cl\u00ednicas de la Leishmaniasis visceral en un servicio de pediatr\u00eda","volume":"37","author":"V\u00e1zquez","year":"2010","journal-title":"Pediatria"},{"key":"10.1016\/j.parint.2015.03.005_bb0075","article-title":"Seroprevalence of canine leishmaniasis in Paraguay","volume":"5","author":"Miret","year":"2013"},{"key":"10.1016\/j.parint.2015.03.005_bb0085","series-title":"Report Leishmaniases No. 1. Epidemiological report of the Americas","author":"Pan American Health Organization","year":"2014"},{"key":"10.1016\/j.parint.2015.03.005_bb0090","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/00034983.1998.11813313","article-title":"Do the diminishing efficacy and increasing toxicity of sodium Stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases","volume":"92","author":"Thakur","year":"1998","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.parint.2015.03.005_bb0095","first-page":"131","article-title":"Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar","volume":"18","author":"Das","year":"2005","journal-title":"Natl Med J"},{"key":"10.1016\/j.parint.2015.03.005_bb0100","first-page":"9","article-title":"Current treatment of leishmaniasis: a review","volume":"1","author":"Monzote","year":"2009","journal-title":"Open Antimic Agents J"},{"key":"10.1016\/j.parint.2015.03.005_bb0105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1258\/td.2008.080369","article-title":"Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil","volume":"39","author":"Oliveira","year":"2009","journal-title":"Trop Doct"},{"key":"10.1016\/j.parint.2015.03.005_bb0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1051\/parasite\/2011182115","article-title":"Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistance","volume":"18","author":"Loiseau","year":"2011","journal-title":"Parasite"},{"key":"10.1016\/j.parint.2015.03.005_bb0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14656566.2013.755515","article-title":"Leishmaniasis: an update of current pharmacotherapy","volume":"14","author":"Sundar","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.parint.2015.03.005_bb0120","first-page":"154","article-title":"Drug discovery and developments in developing countries: bottlenecks and way forward","volume":"7","author":"Nyigo","year":"2005","journal-title":"Tanzan Health Res Bull"},{"key":"10.1016\/j.parint.2015.03.005_bb0125","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.idc.2011.06.002","article-title":"Drugs and diagnostic innovations to improve global health","volume":"25","author":"Peeling","year":"2011","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.parint.2015.03.005_bb0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1874104501105010004","article-title":"Current developments in the therapy of protozoan infections","volume":"5","author":"Zucca","year":"2011","journal-title":"Open Med Chem J"},{"key":"10.1016\/j.parint.2015.03.005_bb0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/anie.199101301","article-title":"Bryophytes, a source of biologically active, naturally occurring material","volume":"30","author":"Zinsmeister","year":"1991","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.parint.2015.03.005_bb0140","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1021\/jf0508044","article-title":"Phytotoxic activity of bibenzyl derivatives from the orchid Epidendrum rigidum","volume":"53","author":"Hern\u00e1ndez-Romero","year":"2005","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.parint.2015.03.005_bb0145","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.2174\/092986706778201611","article-title":"Natural products from plants as drug candidates and lead compounds against leishmaniasis and trypanosomiasis","volume":"13","author":"Salem","year":"2006","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.parint.2015.03.005_bb0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/np060449r","article-title":"Bioactive bibenzyl derivatives and fluorenones from Dendrobium nobile","volume":"70","author":"Zhang","year":"2007","journal-title":"J Nat Prod"},{"key":"10.1016\/j.parint.2015.03.005_bb0155","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1573407211208040002","article-title":"Selected natural and synthetic phenolic compounds with antileishmanial activity: a five-year review","volume":"8","author":"Rojas de Arias","year":"2012","journal-title":"Curr Bioact Compd"},{"key":"10.1016\/j.parint.2015.03.005_bb0160","first-page":"675","article-title":"Bibenzyl derivatives from the liverwort Ricciocarpos natans","volume":"36","author":"Kunz","year":"1994","journal-title":"Int J Plant Biochem"},{"key":"10.1016\/j.parint.2015.03.005_bb0165","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.ejmech.2007.11.007","article-title":"Activity of a hydroxybibenzyl bryophyte constituent against Leishmania spp. and Trypanosoma cruzi: in silico, in vitro and in vivo activity studies","volume":"43","author":"Roldos","year":"2008","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.parint.2015.03.005_bb0170","first-page":"100","article-title":"In vivo analysis of the genotoxic potential of 14-hydroxylunularin, a molecule with leishmanicidal activity","volume":"39","author":"Cuevas","year":"2010","journal-title":"Rev Latinoam Qu\u00edm"},{"key":"10.1016\/j.parint.2015.03.005_bb0175","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.1128\/IAI.69.12.7365-7373.2001","article-title":"Virulence of Leishmania infantum is expressed as a clonal and dominant phenotype in experimental infections","volume":"69","author":"Garin","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.parint.2015.03.005_bb0185","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1128\/AAC.49.12.4950-4956.2005","article-title":"Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral Leishmaniases","author":"Nakayama","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.parint.2015.03.005_bb0195","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.actatropica.2005.12.003","article-title":"Leishmania infantum released proteins specifically regulate cytokine expression and production patterns by CD4+ and CD8+ T cells","volume":"97","author":"Rosa","year":"2006","journal-title":"Acta Trop"},{"key":"10.1016\/j.parint.2015.03.005_bb0205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/AAC.50.1.73-79.2006","article-title":"In vitro and in vivo interactions between miltefosine and other antileishmanial drugs","volume":"50","author":"Seifert","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.parint.2015.03.005_bb0210","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1128\/AAC.50.4.1352-1364.2006","article-title":"Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies","volume":"50","author":"Tasdemir","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.parint.2015.03.005_bb0215","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jac\/dkr409","article-title":"The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis","volume":"67","author":"Rodrigues","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.parint.2015.03.005_bb0220","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0378-8741(92)90074-2","article-title":"Biological and chemical studies of Pera benensis, a Bolivian plant used in folk medicine as a treatment of cutaneous leishmaniasis","volume":"37","author":"Fournet","year":"1992","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.parint.2015.03.005_bb0225","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/jac\/33.3.537","article-title":"The activity of 2-substituted quinoline alkaloids in BALB\/c mice infected with Leishmania donovani","volume":"33","author":"Fournet","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.parint.2015.03.005_bb0230","author":"CIOMS\/ICLAS"},{"key":"10.1016\/j.parint.2015.03.005_bb0235","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1128\/AAC.42.10.2722","article-title":"Visceral Leishmaniasis in the BALB\/c mouse: a comparison of the efficacy of a nonionic surfactant formulation of sodium stibogluconate with those of three proprietary formulations of Amphotericin B","volume":"42","author":"Mullen","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.parint.2015.03.005_bb0240","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.parint.2015.03.005_bb0250","first-page":"399","article-title":"Current scenario of drug development for leishmaniasis","author":"Croft","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.parint.2015.03.005_bb0255","series-title":"S\u00edntesis y Evaluaci\u00f3n biol\u00f3gica de una biblioteca de 2-alquil-1,4-becenodioles con actividad leishmanicida usando m\u00e9todos de qu\u00edmica verde","author":"Peixoto de Abreu","year":"2013"},{"key":"10.1016\/j.parint.2015.03.005_bb0260","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.addr.2009.03.006","article-title":"Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs","volume":"61","author":"Zolnik","year":"2009","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Parasitology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576915000574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576915000574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T01:01:07Z","timestamp":1566522067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383576915000574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1383576915000574"],"URL":"https:\/\/doi.org\/10.1016\/j.parint.2015.03.005","relation":{},"ISSN":["1383-5769"],"issn-type":[{"value":"1383-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Finding of leishmanicidal activity of 14-hydroxylunularin in mice experimentally infected with Leishmania infantum","name":"articletitle","label":"Article Title"},{"value":"Parasitology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parint.2015.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}